Abstract
We reviewed the infectious complications in 207 courses of anticancer chemotherapy to 93 patients with urogenital cancer. Thirty episodes (14.5%) of neutropenic fever containing 9 cases (4.3%) of infection were observed. Five patients (16.7%) had pyelonephritis, one (3.3%) had acute prostatitis, two (6.6%) had pneumonia and one (3.3%) had bacteraemia. Multivariate analysis revealed that the infectious complications during anticancer chemotherapy were mainly associated with urinary diversion, hydronephrosis and duration of severe neutropenia (<500/mm3).
These results suggest that infectious complications should be prevented in patients with urinary diversion, hydronephrosis and severe neutropenia during anticancer chemotherapy for urogenital cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Pizzo, P. A.: Granulocytopenia and cancer therapy: Past problems, current solutions, future challenge. Cancer, 54, 2649 (1984).
Sculier, J. P., Wheets, D., Klastersky, J.: Causes of death in febrile granulocytopenic cancer patients receiving empiric antibiotic therapy. Eur. J. Cancer Clin. Oncol., 20, 55 (1984).
Naito, S., Kuroiwa, T., Ueda, T. et al.: Combination chemotherapy with intra-arterial cisplatin and doxorubicin plus intravenous methotrexate and vincristine for local advanced bladder cancer. J. Urol., 154, 1704 (1995).
Philoppt-Howard, J.: Infections in neutropenic patients. Curr. Opin. Infect. Dis., 8, 234 (1995).
Bodey, G. P., Buckley, M., Sathe, T. S. et al.: Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Ann. Intern. Med., 64, 328 (1966).
Ito, Y., Komeda, H., Saitoh, A. et al.: Infection in genitourinary cancer patients during cancer chemotherapy. Acta Urol. Jpn., 40, 221 (1994).
Maher, D. W., Lieschke, G. J., Green, M. et al.: Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial. Ann. Intern. Med., 121, 492 (1994).
Schimpff, S. C.: Growth factors and empiric therapy with antibiotics: Should they be used concurrently? Ann. Intern. Med., 121, 538 (1994).
Bodey, G. P., Anaissie, E. J., Gutterman, J. et al.: Role of granulocyte-macrophage colony-stimulating factors as adjuvant therapy for fungal infection in patients with cancer. Clin. Infect. Dis., 17, 705 (1993).
Lee, J. W., Pizzo, P. A.: Management of the cancer patient with fever and prolonged neutropenia. Hematol. Oncol. Clin. N. Am., 7, 937 (1993).
Bodey, G. P.: Empirical antibiotic therapy for fever in neutropenic patients. Clin. Infect. Dis., 17(Suppl. 2), 378 (1993).
Klastersky, J.: Empirical therapy for bacterial infections in neutropenic patients. Supprt. Care Cancer, 2, 347 (1994).
Schimpf, S. C., Scott, D. A., Wade, J. C.: Infections in cancer patients; some controversial issue. Supprt Care Cancer, 2, 94 (1994).
Klastersky, J.: Prevention and therapy of fungal infections in cancer patients. A review of recent published information. Supprt Care Cancer, 3, 393 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsumoto, T., Takahashi, K., Tanaka, M. et al. Infectious Complications of Combination Anticancer Chemotherapy for Urogenital Cancers. Int Urol Nephrol 31, 7–14 (1999). https://doi.org/10.1023/A:1007107403610
Issue Date:
DOI: https://doi.org/10.1023/A:1007107403610